| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/23/1993 | CA1314882C Substituted piperidines or azepines, the preparation thereof and their application in therapy |
| 03/23/1993 | CA1314879C Anellated indole derivatives |
| 03/23/1993 | CA1314873C 3-demethylmevalonic acid derivatives, a process for their preparation, pharmaceutical products based on these compounds, their use and intermediates |
| 03/21/1993 | CA2078498A1 Indolesulphonamide-substituted dihydropyridines, processes for their preparation and their use in medicaments |
| 03/19/1993 | CA2078506A1 Benzanilide derivatives |
| 03/19/1993 | CA2078505A1 Benzanilide derivatives |
| 03/18/1993 | WO1993005462A1 Low speed model following velocity command system for rotary wing aircraft |
| 03/18/1993 | WO1993005166A1 Methods for the selection, separation and fusion of cells |
| 03/18/1993 | WO1993005061A1 Cloning and characterization of a cardiac adenylyl cyclase |
| 03/18/1993 | WO1993005045A1 Spirocyclic benzopyran imidazolines |
| 03/18/1993 | WO1993005040A1 Azabicyclic compounds as 5-ht4 receptor antagonists |
| 03/18/1993 | WO1993005038A1 5-ht4 receptor antagonists |
| 03/18/1993 | WO1993005031A1 (3s,4s)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them |
| 03/18/1993 | WO1993005012A1 New compounds |
| 03/18/1993 | WO1993004692A1 Morphogen-induced modulation of inflammatory response |
| 03/18/1993 | WO1993004686A1 Chemical compounds |
| 03/18/1993 | WO1993004682A1 Novel 4-arylpiperazines and 4-arylpiperidines |
| 03/18/1993 | CA2118798A1 Azabicyclic compounds as 5-ht4 receptor antagonists |
| 03/18/1993 | CA2117070A1 Methods for the selection, separation and fusion of cells |
| 03/18/1993 | CA2115161A1 New compounds |
| 03/18/1993 | CA2113818A1 Spirocyclic benzopyran imidazolines |
| 03/18/1993 | CA2095847A1 Novel 4-arylpiperazines and 4-arylpiperidines |
| 03/17/1993 | EP0532410A1 N-substituted heterocyclic derivatives as angiotensin II inhibitors |
| 03/17/1993 | EP0532027A1 Cyclic nitrones, their preparation and pharmaceutical compositions containing them |
| 03/17/1993 | EP0531876A2 Imidazoindolizine derivatives and process for preparation thereof |
| 03/17/1993 | EP0531845A1 Pharmaceutical composition comprising a special crystall modification of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarbonylic acid-(-2-methoxyethyl)-isopropyl ester |
| 03/17/1993 | EP0383759A4 N?6 -substituted 9-methyladenines: a new class of adenosine receptor antagonists |
| 03/17/1993 | CN1020100C Process for benzopyran derivatives |
| 03/16/1993 | US5194605 Cyclic renin inhibitors containing 2-substituted (3S,4S)-4-amino-5-cyclohexyl-3-hydroxy pentanoic acid, 2-substituted (3S,4S)-5-cyclohexyl-3,4-di-hydroxy pentanoic acid or 2-substituted (4S,5S)-5-amino-6-cyclohexyl-4-hydroxyhexanoic acid or its analogs |
| 03/16/1993 | CA1314656C Analogs of gonadoliberin with improved solubility, methods for their preparation, agents containing them and their use |
| 03/16/1993 | CA1314553C Bicyclic compounds, processes for preparation thereof and pharmaceutical composition comprising the same |
| 03/16/1993 | CA1314545C Non-peptidic renin inhibitors |
| 03/16/1993 | CA1314481C Liposomal preparation and antibiotic |
| 03/15/1993 | CA2078058A1 Imidazo-fused iso- and heterocycles, process for their preparation, compositions containing them and their use |
| 03/12/1993 | WO1993004684A1 Novel 4-arylpiperazines and 4-arylpiperidines |
| 03/12/1993 | CA2095826A1 4-arylpiperazines and 4-arylpiperidines |
| 03/11/1993 | CA2077967A1 N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present |
| 03/10/1993 | EP0531119A1 N,N',N'-trisubstituted -5-bis-aminomethylene-1,3-dioxane-4,6-dione inhibitors of acyl-CoA: cholesterol-acyl transferase |
| 03/10/1993 | EP0531078A1 (R)-3-Methoxy-4- 1-methyl-5-(2-methyl-4,4,4-trifluorobutylcarbamoyl)indol-3-ylmethyl -N-(2-methylsulphonyl)benzamide in crystalline form |
| 03/10/1993 | EP0530887A1 Organic nitrates, processes for their preparation and their use in the treatment of cardiovascular diseases |
| 03/10/1993 | EP0530702A1 1,2-dihydro-2-oxopyridines as angiotensin II antagonists |
| 03/10/1993 | EP0530639A1 Quinolylmethoxy-phenylacetamides substituted by a heterocycle as lipoxygenase inhibitors |
| 03/10/1993 | EP0530505A2 Hydantoin derivatives |
| 03/10/1993 | EP0530446A2 Use of sulfur containing carboxylic acids for combatting pathophysiologic excitatory disorders and related diseases as well as allergic diseases and their preparation as medicament |
| 03/10/1993 | EP0530444A1 Aryl, amide, imide, and carbamate pyridine antagonists of platelet activating factor |
| 03/10/1993 | EP0530198A1 Heterocyclic compounds as aldose reductase inhibitors |
| 03/10/1993 | EP0439570B1 A novel use of beta-receptor blocking agents for treatment of menieres' disease |
| 03/10/1993 | CN1069732A 1,7-Condensed 2-(piperazinealkyl)-indole derivatives and process for preparing same and intermediate and pharmaceutical containing same |
| 03/10/1993 | CN1069656A Pharmaceutical based on plants for raising and adjusting tension of smooth muscle organ |
| 03/10/1993 | CA2050948A1 5-benzyl substituted-benzimidazo-line-2-thion derivatives and a process for preparing the same |
| 03/09/1993 | US5192775 New aminomethylpiperidine compounds |
| 03/09/1993 | US5192770 Serotonergic alpha-oxoacetamides |
| 03/09/1993 | US5192763 Antiischemic agents, anticonvulsants |
| 03/09/1993 | US5192760 3-carbalkoxyamino-5-(alpha-aminopropionyl)-5H-dibenz[b,f]azepines and method for their making |
| 03/09/1993 | US5192746 Cyclic cell adhesion modulation compounds |
| 03/09/1993 | CA1314290C Hydroxamic acids of 7-oxabicycloheptane substituted ethers |
| 03/09/1993 | CA1314286C Process for the preparation of eburnamenine derivatives |
| 03/09/1993 | CA1314230C Mixtures for treating hypercholesterolemia |
| 03/09/1993 | CA1314219C Use of exogenous gangliosides in tumoral diseases as a protective factor against toxicity by antitumoral drugs |
| 03/07/1993 | CA2077465A1 Heterocyclically substituted quinolylmethoxy-phenylacetamides |
| 03/06/1993 | CA2076722A1 Pharmaceutical agents |
| 03/05/1993 | CA2077412A1 1,2-dihydro-2-oxopyridines |
| 03/04/1993 | WO1993004373A1 Calcium receptor active molecules |
| 03/04/1993 | WO1993004064A1 Cyclic urethanes useful as antiarrhythmic and antifibrillatory agents |
| 03/04/1993 | WO1993004061A1 Novel 4-oxocyclic ureas useful as antiarrhythmic and antifibrillatory agents |
| 03/04/1993 | WO1993004060A1 Novel cyclic ureas useful as antiarrhythmic and antifibrillatory agents |
| 03/04/1993 | WO1993004052A1 Amide tetrazole acat inhibitors |
| 03/04/1993 | WO1993004048A1 New pyrazine derivatives, their preparation and their use |
| 03/04/1993 | WO1993004046A1 Angiotensin ii receptor blocking imidazolinone derivatives |
| 03/04/1993 | WO1993004045A1 Angiotensin ii receptor blocking imidazolinone derivatives |
| 03/04/1993 | WO1993004035A1 New 3,5-di-tert.butyl-4-hydroxyphenyl derivatives, methods of preparing them and drugs containing them |
| 03/04/1993 | WO1993003755A2 Use of relaxin in cardiovascular therapy and in the treatment of neurodegenerative diseases |
| 03/04/1993 | WO1993003738A1 Method for treating vascular obstructions caused by abnormal cells |
| 03/04/1993 | WO1993003730A1 Protein kinase c inhibition and novel compound balanol |
| 03/04/1993 | WO1993003725A1 5-ht4 receptor antagonists |
| 03/04/1993 | WO1993003722A1 Imidazolyl-alkenoic acids |
| 03/04/1993 | WO1993000313A3 Sigma receptor ligands and the use thereof |
| 03/04/1993 | WO1993000094A3 Use of tetrahydrobenzazepine derivatives for the treatment of portal hypertension and migraine |
| 03/04/1993 | CA2116024A1 5-ht4 receptor antagonists |
| 03/04/1993 | CA2115994A1 Protein kinase c inhibition and novel compound balanol |
| 03/04/1993 | CA2115990A1 Angiotensin ii receptor blocking imidazolinone derivatives |
| 03/04/1993 | CA2115989A1 Angiotensin ii receptor blocking imidazolinone derivatives |
| 03/04/1993 | CA2115755A1 New pyrazine derivatives, their preparation and their use |
| 03/04/1993 | CA2115361A1 Method for treating vascular obstructions caused by abnormal cells |
| 03/04/1993 | CA2115349A1 New 3,5-di-tert-butyl-4-hydroxyphenyl derivatives, processes for their preparation and medicaments |
| 03/03/1993 | EP0530166A2 3-Hydroxy anthranilic acid derivatives for inhibiting 3-hydroxy anthranilate oxygenase |
| 03/03/1993 | EP0529854A2 Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds and their use as HMG-COA reductase inhibitors |
| 03/03/1993 | EP0529702A1 Dihydropyridine derivatives, their preparation and their use |
| 03/03/1993 | EP0529654A1 Benzopyran derivatives as potassium channel activators and 5-lipoxygenase inhibitors |
| 03/03/1993 | EP0529622A2 Cloning and characterization of a cardiac adenylyl cyclase |
| 03/03/1993 | EP0529499A1 Compositions for topical administration to the nose or the eyes containing bradykinin antagonists |
| 03/03/1993 | EP0529462A1 Benzodioxan derivatives |
| 03/03/1993 | EP0529452A2 1,7-Condensed 2-(piperazinoalkyl)indol derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them |
| 03/03/1993 | EP0529450A1 Substituted mandelic acid derivatives as 5-lipoxygenase inhibitors |
| 03/03/1993 | EP0529253A1 Phenylalkylderivatives, compounds containing them and process for their fabrication |
| 03/03/1993 | EP0529226A1 p-Oxybenzoic acid derivatives, process for preparing them and their use as medicaments |
| 03/03/1993 | EP0528957A1 Five-membered ring alkanoic acid leukotriene antagonists |
| 03/03/1993 | EP0528922A1 New sulfonyl compounds |
| 03/03/1993 | EP0321516B1 3-indolepyruvic acid derivatives and pharmaceutical use thereof |
| 03/03/1993 | EP0315698B1 Thieno(triazolo)diazepine compounds and medicinal application of the same |